Gloria Heredia

Oct 26, 2023 | mdpi.com | Gloria Heredia |Rafael González-Manzanares |Soledad Ojeda |José Molina

1. IntroductionAcute lymphoblastic leukemia (ALL) is the most prevalent type of cancer in the pediatric population. Over the past few decades, anthracycline-based therapies have significantly improved survival rates in these patients [1]. However, due to the exposition to cardiotoxic agents, childhood leukemia survivors (CLS) have an increased risk of cardiovascular disease during their lifetimes [2].